Loading…
Loading…
| # | Company | Status |
|---|---|---|
| 1 | Admitted-Finance | Admitted-Finance |
| 2 | Admitted-Finance PLOT NO 2117 A 2 PHASE II II G I D C VAPI GUJARAT INDIA 396195 | VAPI | VALSAD | GUJARAT | 396195 | Admitted-Finance |
| 3 | Admitted-Finance | Admitted-Finance |
| 4 | Admitted-Finance NARENGI GUWAHATI ASSAM 781026 | KAMRUP METRO | ASSAM | 781026 | Admitted-Finance |
| 5 | Admitted-Finance | Admitted-Finance |
Tender Value
Refer Docs
Closing Date
14 Jan 2022, 4:30 pmClosed
Managing Director, PHSC, Mohali
PHSC , Punjab School Education Board Complex, 2nd Floor Phase-8,Mohali
Medicine under Other Programme
2021_DHFW_75488_3
PHSC/Proc./RC Med./21-22/19
Open Tender
Miscellaneous Goods
Item Wise
42 days
Managing Director, PHSC, Mohali
Please refer Tender documents.
2 documents required · 2 mandatory
₹1,000
Exempted
PHSC, Mohali
3 Mar 2022
30 Oct 2021
17 Jan 2022
30 Oct 2021
14 Jan 2022
25 Nov 2021
17 Nov 2021
Medicine (Other Programs)
Buprenorphine/naloxone combination Sublingual Tab. 2/0.5mg
Naltrexone Tab. 50mg
Risperidone Tab 1 mg
Inj Naloxone 0.4mg
Tab Haloperidol
Tab Sodium Valproate 300mg SR/CR
Tab Sodium Valproate 300mg SR/CR
Tab Clonzepam 2mg
Syrup Oseltamivir 12 mg/ml
Cap. Oseltamvir 45 mg
Synokem Pharmaceuticals Ltd.
RUSAN PHARMA LTD
UNIMARCK HEALTHCARE LIMITED
MAAN PHARMACEUTICALS LTD
MicronPharmaceuticals
Verve Human Care Laboratories
UNIMARCK HEALTHCARE LIMITED
RUSAN PHARMA LTD
Samarth Life Sciences Pvt. Ltd
stage.html
html • 0.04 MB
tech_eval.pdf
boq_comp_chart.xlsx
xlsx
Tap a document below to read it instantly. You can also download everything as a ZIP if you prefer.
details.html
html • 0.03 MB
Download all tender documents and submit your bid
Disclaimer: TenderKart has made every reasonable effort to ensure that the information on this page is accurate and authentic, however it cannot be held liable for any third-party claims or losses or any damages. TenderKart makes no warranty, expressed or implied, as to the results obtained from the use of this information. If you notice any error or omission, please let us know at .